{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:51:42Z","timestamp":1776505902168,"version":"3.51.2"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,18]]},"DOI":"10.7759\/cureus.107276","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:29:13Z","timestamp":1776504553000},"source":"Crossref","is-referenced-by-count":0,"title":["Avacopan-Assisted Remission of Diffuse Alveolar Hemorrhage in Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Mahmood Yassin","family":"Alattas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah Mohammad","family":"Albihani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma Mohammed","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghalia Abdullah","family":"Alarwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawan Naif","family":"Alraddadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1070","article-title":"ANCA associated vasculitis","volume":"369","author":"Hunter RW","year":"2020","unstructured":"Hunter RW, Welsh N, Farrah TE, Gallacher PJ, Dhaun N. ANCA associated vasculitis. BMJ. 2020, 369:m1070. 10.1136\/bmj.m1070","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/7m21vr","article-title":"Analysis of risk factors associated with diffuse alveolar haemorrhage in patients with ANCA-associated vasculitis and construction of a risk prediction model using line graph","volume":"42","author":"Li X","year":"2024","unstructured":"Li X, Ma C, Xu J, et al.. Analysis of risk factors associated with diffuse alveolar haemorrhage in patients with ANCA-associated vasculitis and construction of a risk prediction model using line graph. Clin Exp Rheumatol. 2024, 42:864-71. 10.55563\/clinexprheumatol\/7m21vr","journal-title":"Clin Exp Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.41773","article-title":"American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung SA","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, et al.. American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2021, 73:1366-83. 10.1002\/art.41773","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.008","article-title":"KDIGO 2024 clinical practice guideline for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"105","author":"Floege J","year":"2024","unstructured":"Floege J, Jayne DR, Sanders JS, et al.. KDIGO 2024 clinical practice guideline for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Kidney Int. 2024, 105:S71-S116. 10.1016\/j.kint.2023.10.008","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae020","article-title":"Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhage","volume":"39","author":"Chalkia A","year":"2024","unstructured":"Chalkia A, Flossmann O, Jones R, et al.. Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhage. Nephrol Dial Transplant. 2024, 39:1473-82. 10.1093\/ndt\/gfae020","journal-title":"Nephrol Dial Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne DR","year":"2021","unstructured":"Jayne DR, Merkel PA, Schall TJ, Bekker P. Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med. 2021, 384:599-609. 10.1056\/NEJMoa2023386","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-025-01068-0","article-title":"Avacopan for severe pulmonary hemorrhage requiring extracorporeal membrane oxygenation in a patient with MPO-ANCA positive vasculitis","volume":"15","author":"Endo K","year":"2026","unstructured":"Endo K, Hayashi K, Hara Y, et al.. Avacopan for severe pulmonary hemorrhage requiring extracorporeal membrane oxygenation in a patient with MPO-ANCA positive vasculitis. CEN Case Rep. 2026, 15:39. 10.1007\/s13730-025-01068-0","journal-title":"CEN Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar C","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, et al.. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009, 68:1827-32. 10.1136\/ard.2008.101279","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette JC","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al.. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013, 65:1-11. 10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1067\/j.cpradiol.2014.01.002","article-title":"Diffuse pulmonary hemorrhage: clues to the diagnosis","volume":"43","author":"Lichtenberger JP III","year":"2014","unstructured":"Lichtenberger JP III, Digumarthy SR, Abbott GF, Shepard JA, Sharma A. Diffuse pulmonary hemorrhage: clues to the diagnosis. Curr Probl Diagn Radiol. 2014, 43:128-39. 10.1067\/j.cpradiol.2014.01.002","journal-title":"Curr Probl Diagn Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61071117","article-title":"Association between hearing loss and systemic small-vessel vasculitis: audiological aspects across disease types","volume":"61","author":"Vainutien\u0117 V","year":"2025","unstructured":"Vainutien\u0117 V, Lesinskas E, Iva\u0161kien\u0117 T, Mieliauskait\u0117 D, Dadonien\u0117 J, Miltinien\u0117 D, Iva\u0161ka J. Association between hearing loss and systemic small-vessel vasculitis: audiological aspects across disease types. Medicina (Kaunas). 2025, 61:1117. 10.3390\/medicina61071117","journal-title":"Medicina (Kaunas)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.70338","article-title":"The complement system in ANCA-associated vasculitis: mechanistic insights, therapeutic horizons, and unmet clinical needs","volume":"14","author":"Sunmboye K","year":"2026","unstructured":"Sunmboye K, Millan P. The complement system in ANCA-associated vasculitis: mechanistic insights, therapeutic horizons, and unmet clinical needs. Immun Inflamm Dis. 2026, 14:e70338. 10.1002\/iid3.70338","journal-title":"Immun Inflamm Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-025-00569-w","article-title":"Efficacy and safety of avacopan in the treatment of ANCA-associated vasculitis: a systematic review and meta-analysis","volume":"9","author":"Aldhuaina K","year":"2025","unstructured":"Aldhuaina K, Alghanim K. Efficacy and safety of avacopan in the treatment of ANCA-associated vasculitis: a systematic review and meta-analysis. BMC Rheumatol. 2025, 9:115. 10.1186\/s41927-025-00569-w","journal-title":"BMC Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S314421","article-title":"ANCA-associated vasculitis clinical presentation and clinical predictors of relapse in Saudi Arabia","volume":"13","author":"Alahmari H","year":"2021","unstructured":"Alahmari H, Daajani HA, Alsayed F, Alrashid A. ANCA-associated vasculitis clinical presentation and clinical predictors of relapse in Saudi Arabia. Open Access Rheumatol. 2021, 13:213-20. 10.2147\/OARRR.S314421","journal-title":"Open Access Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/478155-avacopan-assisted-remission-of-diffuse-alveolar-hemorrhage-in-myeloperoxidase-antineutrophil-cytoplasmic-antibody-associated-vasculitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:29:13Z","timestamp":1776504553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/478155-avacopan-assisted-remission-of-diffuse-alveolar-hemorrhage-in-myeloperoxidase-antineutrophil-cytoplasmic-antibody-associated-vasculitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.107276","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,18]]}}}